Regulatory Press Releases

2025

Stille AB (publ) informs that Niklas Carlén has decided to step down from his position as Chief Financial Officer (CFO) of Stille to pursue a new opportunity outside the company. "I would like to thank Niklas for his significant contributions over the past five years and wish him all the best in his future endeavors. He has played an important role in many key initiatives at Stille, including...
2025-04-24 08:00 Stille AB: Interim Report Q1 2025 Regulatory MAR
Stille AB (publ) today presents the report for the first quarter 2025. Revenue amounted to 129.3 MSEK (139.7) impacted by temporary delivery restrictions and the phase-out of non-strategic products.“Stille starts 2025 with a quarter marked by temporary challenges.” says Torbjörn Sköld but also points out,“Order intakeremained strong, in line with financial targets, providing...
2025-04-09 09:00 Notice of Annual General Meeting of Stille AB Regulatory
Stille AB holds its annual general meeting on Wednesday, May 7, 2025, at 13:00 CEST, at Bygget Fest & Konferens on Norrlandsgatan 11 in Stockholm, Sweden. Registration starts at 12:30 CEST. REQUIREMENTS FOR PARTICIPATION Shareholders wishing to attend the meeting shall: Notification of attendance may be made in writing to the company on the address Stille AB, Att: Annual general meeting 2025, Ekbacken...
2025-04-04 08:00 Stille AB: Annual Report 2024 Regulatory
Today, Stille AB publishes the annual report for 2024. The report can be found on the company website www.stille.se. A full translated version in English will be provided on Stille’s website latest April 29th. Torshälla, April 4th, 2025. Contact DetailsTorbjörn SköldCEO & President+46 (0)70 316 63 91 | torbjorn.skold@stille.se About UsStille AB (publ) develops, manufactures...
2025-02-13 08:00 Stille AB: Year-end Report 2024 Regulatory MAR
Stille AB (publ) today presents the report for the fourth quarter and full year 2024. Revenue amounted to MSEK 159.8 (77.3) driven by strong organic growth in surgical instruments, the successful acquisition of Fehling and solid growth in the US. Total growth amounted to 106.4 percent, of which 22.0 percent was organic growth.“Earnings growth remains solid with an adjusted EBITDA margin of 28.4...